Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanGraft vs Host DiseaseTreatment OutcomeCombined Modality TherapyHematologic NeoplasmsBone Marrow TransplantationRemission InductionSalvage TherapyDisease-Free SurvivalRecurrenceHodgkin DiseaseCyclophosphamideEtoposideHematopoietic Stem Cell MobilizationMyeloablative AgonistsLymphoma, Non-HodgkinTransplantationRetrospective StudiesSurvival RateAntigens, CD34CytarabineTissue DonorsHistocompatibility TestingCarmustineStem Cell NicheSurvival AnalysisBone Marrow PurgingWhole-Body IrradiationGraft SurvivalThiotepaTransplantation ChimeraVincristineFollow-Up StudiesBusulfanCell DifferentiationAdult Stem CellsHematopoiesisAmyloidosisImmunocompromised HostImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseLymphoma, Mantle-CellPrognosisEmbryonic Stem CellsMesenchymal Stem Cell TransplantationBoronic AcidsDoxorubicinPyrazinesDexamethasoneTime FactorsLeukemiaAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic AgentsThalidomideKidney TransplantationAntineoplastic Agents, AlkylatingLymphoma, T-Cell, PeripheralGranulocyte Colony-Stimulating FactorAutograftsBone MarrowCell LineageBone Marrow CellsLiver TransplantationCord Blood Stem Cell TransplantationIfosfamideLymphomaLeukapheresisFlow CytometryPluripotent Stem CellsInduction ChemotherapyLeukemia, Myeloid, AcuteMice, Inbred C57BLPrednisoneHLA AntigensCell TransplantationPancytopeniaAnemia, AplasticPodophyllotoxinCells, CulturedNeoplasm, ResidualHistocompatibilityLymphoma, Large B-Cell, DiffuseCytomegalovirus InfectionsMaintenance ChemotherapyProspective StudiesNeural Stem CellsMyelodysplastic SyndromesMesenchymal Stromal CellsFetal Blood